Impressive Results With Fingolimod in Pediatric MS Impressive Results With Fingolimod in Pediatric MS

In the first randomized trial in pediatric multiple sclerosis, fingolimod was associated with sizable reductions in relapse rate, new MRI lesions, brain atrophy, and disability progression compared with interferon beta.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news